nitrates has been researched along with Arrhythmogenic Right Ventricular Dysplasia in 2 studies
Nitrates: Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical.
Arrhythmogenic Right Ventricular Dysplasia: A congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the RIGHT VENTRICLE wall and loss of myocardial cells. Primary injuries usually are at the free wall of right ventricular and right atria resulting in ventricular and supraventricular arrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We used a murine model of arrhythmogenic right ventricular cardiomyopathy (ARVC) to test whether reducing ventricular load prevents or slows development of this cardiomyopathy." | 1.37 | Load-reducing therapy prevents development of arrhythmogenic right ventricular cardiomyopathy in plakoglobin-deficient mice. ( Breithardt, G; Coronel, R; de Bakker, JM; Ebnet, K; Fabritz, L; Fortmueller, L; Franke, WW; Hoogendijk, MG; Kirchhof, P; Kreienkamp, N; Laakmann, S; Levkau, B; Noppinger, PR; Piccini, I; Pieperhoff, S; Scicluna, BP; van Amersfoorth, SC; Wichter, T; Witt, H; Wolf, S, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calkins, H | 1 |
| Fabritz, L | 1 |
| Hoogendijk, MG | 1 |
| Scicluna, BP | 1 |
| van Amersfoorth, SC | 1 |
| Fortmueller, L | 1 |
| Wolf, S | 1 |
| Laakmann, S | 1 |
| Kreienkamp, N | 1 |
| Piccini, I | 1 |
| Breithardt, G | 1 |
| Noppinger, PR | 1 |
| Witt, H | 1 |
| Ebnet, K | 1 |
| Wichter, T | 1 |
| Levkau, B | 1 |
| Franke, WW | 1 |
| Pieperhoff, S | 1 |
| de Bakker, JM | 1 |
| Coronel, R | 1 |
| Kirchhof, P | 1 |
2 other studies available for nitrates and Arrhythmogenic Right Ventricular Dysplasia
| Article | Year |
|---|---|
Use of mouse models to evaluate novel therapeutic approaches to treatment of arrhythmogenic right ventricular cardiomyopathy the future is now.
Topics: Animals; Arrhythmogenic Right Ventricular Dysplasia; Cardiac Volume; Diuretics; Furosemide; Nitrates | 2011 |
Load-reducing therapy prevents development of arrhythmogenic right ventricular cardiomyopathy in plakoglobin-deficient mice.
Topics: Animals; Arrhythmogenic Right Ventricular Dysplasia; Cardiac Volume; Connexin 43; Disease Models, An | 2011 |